fenclonine has been researched along with Remission, Spontaneous in 1 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casacchia, M | 1 |
| Casati, C | 1 |
| Fazio, C | 1 |
1 trial available for fenclonine and Remission, Spontaneous
| Article | Year |
|---|---|
Letter: p-Chlorophenylalanine in schizophrenia.
Topics: Administration, Oral; Clinical Trials as Topic; Drug Evaluation; Fenclonine; Humans; Remission, Spon | 1975 |